Hvivo PLC (LON:HVO) insider James Winschel bought 2,221 shares of the business’s stock in a transaction that occurred on Tuesday, October 11th. The stock was acquired at an average cost of GBX 180 ($2.23) per share, with a total value of £3,997.80 ($4,947.77).

Hvivo PLC (LON:HVO) opened at 171.4375 on Wednesday. The company has a 50 day moving average of GBX 178.92 and a 200-day moving average of GBX 186.41. Hvivo PLC has a 12-month low of GBX 167.00 and a 12-month high of GBX 282.50. The stock’s market capitalization is GBX 133.83 million.

Separately, Numis Securities Ltd reissued an “add” rating and issued a GBX 210 ($2.60) target price on shares of Hvivo PLC in a report on Thursday, September 22nd.

About Hvivo PLC

hVIVO plc, formerly Retroscreen Virology Group plc, is a holding company. The Company is engaged in a life sciences business pioneering a technology platform of human disease models to accelerate drug discovery and development in respiratory and infectious diseases, including flu, respiratory syncytial virus (RSV), asthma and common cold.

Receive News & Stock Ratings for Hvivo PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hvivo PLC and related stocks with our FREE daily email newsletter.